Prioré-Type EM
Oncology research platform — Prioré framework multi-frequency EM delivery
Delivers rotating multi-frequency magnetic fields modulated by a plasma-coupled RF carrier to the full body. The rotating field geometry ensures uniform coverage across tumor regions regardless of orientation. Simultaneous multi-frequency delivery (5 independent frequency channels) creates the complex field superposition Prioré documented as necessary for biological effect. All sessions are monitored with real-time field strength measurement and patient safety cutoffs.
The Prioré-Type EM system is based on Antoine Prioré's 1960s–1970s research in Bordeaux, France, where he documented significant tumor regression in animal subjects using a device that combined rotating magnetic fields, microwaves, and plasma-modulated EM delivery. Prioré's device was authenticated by prominent French scientists (including Nobel laureate Louis Néel) before funding was terminated under institutional pressure. This system recreates the core electromagnetic architecture: rotating multi-frequency magnetic fields (0.1–10 MHz) modulated by a plasma-coupled RF carrier, delivered via a full-body coil geometry. For oncology research use only — no therapeutic claims are made.
- Rotating magnetic field coil array (5-axis, 0.1–10 MHz)
- Plasma-coupled RF modulation stage (10–100 MHz)
- Multi-frequency waveform synthesizer (5 independent channels)
- Full-body coil geometry enclosure
- Real-time field strength monitoring (safety interlock)
- Oncology research protocol library (Prioré-documented frequencies)
| Component | Est. Cost |
|---|---|
| Rotating magnetic field coil array (5-axis) | $2,200 |
| Plasma-coupled RF modulation stage | $1,600 |
| Multi-frequency waveform synthesizer (5-ch) | $1,400 |
| Full-body coil enclosure + positioning system | $980 |
| Safety monitoring + interlock system | $580 |
| Power systems + wiring | $325 |
Supplier names not shown on this page. Full sourcing guide included with institutional purchase. Volume pricing available — see note below.